Business Insider
My Markets Watchlist
Markets Stocks

Ventas Inc. Stock , VTR

63.39 -0.07 -0.11%
03:23:36 PM BTT
News Analyst Data Analyst Opinions Insider Activity Dividend Calendar

On Wednesday morning 06/11/2025 the Ventas Inc. share started trading at the price of $63.58. Compared to the closing price on Tuesday 06/10/2025 on BTT of $63.46, this is a gain of 0.19%. There are 451.30 M shares outstanding in Ventas Inc., which values the company at $23.57 B.
Is Ventas stock a Buy, Sell or Hold? Ventas stock has received a consensus rating of buy. The average rating score is and is based on 16 buy ratings, 10 hold ratings, and 0 sell ratings.
What was the 52-week low for Ventas stock? The low in the last 52 weeks of Ventas stock was 49.35. According to the current price, Ventas is 128.41% away from the 52-week low.
What was the 52-week high for Ventas stock? The high in the last 52 weeks of Ventas stock was 71.33. According to the current price, Ventas is 88.84% away from the 52-week high.
What are analysts forecasts for Ventas stock? The 26 analysts offering price forecasts for Ventas have a median target of 57.15, with a high estimate of 78.00 and a low estimate of 44.00. The median estimate represents a 110.88 difference from the last price of 63.37.

Ventas Stock Snapshot

63.38
Bid
100.00
Bid Size
63.42
Ask
40.00
Ask Size
6/11/2025
Date
3:23 PM
Time
100,863.00
Volume
63.46
Prev. Close
63.58
Open
28.63 B
Market Cap in USD
451.30 M
Number of Shares
451.30 M
Total Number of Shares
63.02
Day Low
64.02
Day High
63.39
49.35
52 Week Low
71.33
52 Week High
63.39
1.80
Dividend in USD
3.06
Dividend Yield
302.15
P/E Ratio
99.50
Free Float in %
0.19
EPS in USD
24.64
Book Value per Share in USD
3.21
Cash Flow per Share in USD

Historical Prices for Ventas

Loading..
Date Open Close Daily High Daily Low
Price change over selected period: 0% 0

Ventas Analyst Data

Total Analysts: 26
Buy Ratings: 16 Neutral Ratings: 10 Sell Ratings: 0
Analyst: {{ANALYST_DATA}}
Price-Target: {{PRICE_DATA}}
Rating: {{RATING_DATA}}
Price *Price Target
Lowest: 44.00 Median: 57.15 Highest: 78.00
*The average price target includes all analyst analysis, not just the most recent analysis presented in the chart.

Ventas Analyst Opinions

  • All
  • Buy
  • Hold
  • Sell
Date Analyst Rating Price
05/07/25 RBC Capital Markets
Maintained Buy $75
03/18/25 Mizuho
Maintained Buy $75
03/11/25 Morgan Stanley
Maintained Hold $70
03/10/25 Wells Fargo & Co
Maintained Buy $77
03/07/25 J.P. Morgan
Maintained Hold $73
02/25/25 RBC Capital Markets
Maintained Buy $74
02/14/25 Wedbush Morgan Securities Inc.
Maintained Buy $78
07/16/24 Evercore
Maintained Buy $56
05/30/24 Wells Fargo & Co
Maintained Hold $49
03/18/24 Evercore
Upgraded to Buy $50
02/26/24 Wells Fargo & Co
Downgraded to Hold $46
01/30/24 Deutsche Bank
Maintained Buy $60
01/16/24 Bank of America Merrill Lynch
Upgraded to Buy $53
01/03/24 Mizuho
Maintained Buy $56
11/13/23 Wells Fargo & Co
Maintained Buy $47
11/07/23 Wedbush Morgan Securities Inc.
Upgraded to Buy $51
10/11/23 Exane BNP Paribas
Maintained Buy
10/03/23 Wedbush Morgan Securities Inc.
Maintained Hold $44
09/22/23 BMO Capital Markets
Maintained Buy $51
09/20/23 Raymond James Financial, Inc.
Downgraded to Buy $53
09/07/23 Morgan Stanley
Maintained Hold $47
08/30/23 J.P. Morgan
Maintained Hold $48
08/11/23 Bank of America Merrill Lynch
Downgraded to Hold $48
08/09/23 RBC Capital Markets
Maintained Buy $53
07/20/23 Morgan Stanley
Maintained Hold $45
06/27/23 Citigroup Corp.
Maintained Buy $52
06/23/23 Raymond James Financial, Inc.
Upgraded to Buy $55

Ventas Estimates* in USD

  2025 2026 2027 2028
Revenue 5,534 6,008 6,581 7,168
Dividend 1.93 2.03 2.14 2.29
Dividend Yield (in %) 3.04 % 3.21 % 3.37 % 3.60 %
EPS 0.54 0.77 1.00 -
P/E Ratio 118.25 82.24 63.46 -
EBIT 596 904 1,108 -
EBITDA 2,182 2,410 2,631 2,921
Net Profit 193 325 413 29
Net Profit Adjusted 189 310 268 29
Pre-Tax Profit 444 561 759 2,056
Pre-Tax Profit Reported 248 372 523 -
EPS (Non-GAAP) ex. SOE - - - -
EPS (GAAP) 0.54 0.77 1.00 -
Gross Income 2,318 2,550 2,849 -
Cash Flow from Investing -1,988 -2,534 - -
Cash Flow from Operations 1,537 1,753 - -
Cash Flow from Financing 49 686 - -
Cash Flow per Share 3.48 3.81 4.11 -
Free Cash Flow 1,591 1,773 1,600 1,760
Free Cash Flow per Share 2.87 3.10 3.39 3.73
Book Value per Share 23.42 21.81 20.33 -
Net Debt 12,721 13,150 13,544 14,045
Research & Development Exp. - - - -
Capital Expenditure 474 496 779 1,736
Selling, General & Admin. Exp. 171 179 - -
Shareholder’s Equity 11,264 11,412 10,436 8,085
Total Assets 26,690 26,908 26,690 -
  Previous Quarter
ending 03/31/25 		Current Quarter
ending 06/30/25 		Next Quarter
ending 09/30/25 		Current Year
ending 12/31/25 		Next Year
ending 12/31/26
Earnings Estimates
No. of Analysts - 6 6 6 6
Average Estimate - 0.132 USD 0.147 USD 0.537 USD 0.772 USD
Year Ago - 0.048 USD 0.046 USD 0.197 USD -
Publish Date - 7/31/2025 10/30/2025 - -
Revenue Estimates
No. of Analysts - 10 10 13 13
Average Estimate - 1,369 USD 1,398 USD 5,534 USD 6,008 USD
Year Ago - 1,201 USD 1,236 USD 4,947 USD -
Publish Date - 7/31/2025 10/30/2025 - -
* Average Estimates in Million (e.g. Revenue) or per share (e.g. Dividend). Source: FactSet

Income Statements in Mio. USD

2024 2023 2022 2021 2020 2019 2018
Sales 4,946.57 4,497.83 4,129.19 3,828.01 3,795.36 3,872.75 3,745.81
Change of sales in % 9.98 8.93 7.87 0.86 -2.00 3.39 4.80
Gross profit on sales 918.65 770.72 756.28 761.51 899.64 1,150.20 1,164.37
Gross profit on sales change in % 19.19 1.91 -0.69 -15.35 -21.78 -1.22 -5.89
Operating income 706.25 665.12 533.38 603.72 744.53 1,001.82 945.62
Operating income change in % 6.18 24.70 -11.65 -18.91 -25.68 5.94 -12.58
Income before tax 50.58 -98.09 -57.86 61.39 344.65 382.99 376.04
Income before tax change in % - -69.54 - -82.19 -10.01 1.85 -35.63
Income after tax 81.15 -40.97 -47.45 49.01 439.15 433.02 409.48
Income after tax change in % - 13.64 - -88.84 1.42 5.75 -69.82

Balance Sheet in Mio. USD

2024 2023 2022 2021 2020 2019 2018
Total liabilities 15,047.08 14,878.39 13,671.51 13,491.74 13,415.72 13,873.08 12,124.82
Long-term liabilities per share - - - - - - -
Equity 11,139.83 9,847.04 10,486.33 11,226.04 10,513.68 10,819.13 10,459.74
Equity change in % 13.52 -6.55 -6.46 6.62 -2.54 2.25 -5.99
Balance sheet total 26,186.91 24,725.43 24,157.84 24,717.79 23,929.40 24,692.21 22,584.56
Balance sheet total change in % 5.91 2.35 -2.27 3.29 -3.09 9.33 -5.72

Key Data in USD

2024 2023 2022 2021 2020 2019 2018
Sales per share 11.88 11.19 11.06 9.91 10.08 10.47 10.43
P/E ratio (year end quote, basic EPS) 302.15 - - 402.84 42.04 49.32 51.41
P/E ratio (year end quote, diluted EPS) 302.15 - - 402.84 42.04 49.32 51.41
Dividend yield in % 3.06 3.61 4.00 3.52 4.37 5.49 5.40
Equity ratio in % 42.54 39.83 43.41 45.42 43.94 43.82 46.31
Debt ratio in % 57.46 60.17 56.59 54.58 56.06 56.18 53.69

Ventas Insider Activity

Name Date shares traded shares held Price type (sell/buy) option
Roberts Carey S. 05/29/2025 23,500.00 116,650.00 64.23 Sell No
Probst Robert F 05/26/2025 17,374.00 168,364.00 65.22 Sell No
Probst Robert F 05/26/2025 17,374.00 185,738.00 62.22 Buy No
Probst Robert F 05/20/2025 33,592.00 168,364.00 64.57 Sell No
Probst Robert F 05/20/2025 36,000.00 168,364.00 64.62 Sell No
Probst Robert F 05/20/2025 33,592.00 201,956.00 53.79 Buy No
Smith Maurice S 05/12/2025 2,882.00 26,080.44 64.18 Buy No
CAFARO DEBRA A 05/01/2025 1,212.00 1,145,695.00 66.45 Sell No
CAFARO DEBRA A 05/01/2025 1,212.00 1,146,907.00 65.45 Buy No
CAFARO DEBRA A 04/30/2025 9,110.00 1,145,695.00 66.04 Sell No
CAFARO DEBRA A 04/30/2025 9,110.00 1,154,805.00 65.45 Buy No
LUSTIG MATTHEW J 04/16/2025 246.17 86,965.08 67.93 Buy No
Roy Sumit 04/16/2025 55.23 17,263.21 67.93 Buy No
LUSTIG MATTHEW J 04/16/2025 55.23 87,020.31 67.93 Buy No
Roy Sumit 04/16/2025 43.72 17,207.98 67.93 Buy No
Smith Maurice S 04/16/2025 52.08 23,143.21 67.93 Buy No
Smith Maurice S 04/16/2025 55.23 23,198.44 67.93 Buy No
Martino Roxanne M 04/16/2025 192.59 57,551.64 67.93 Buy No
Rodriguez Joe Vasquez Jr. 04/16/2025 26.38 4,787.52 67.93 Buy No
NADER MARGUERITE M 04/16/2025 55.23 18,254.43 67.93 Buy No
Liebbe Gregory R 04/04/2025 1,001.00 13,900.58 65.51 Sell No
CAFARO DEBRA A 04/02/2025 7,062.00 1,145,695.00 71.06 Sell No
CAFARO DEBRA A 04/02/2025 37,489.00 1,145,695.00 71.06 Sell No
CAFARO DEBRA A 04/02/2025 7,062.00 1,152,757.00 65.45 Buy No
CAFARO DEBRA A 04/02/2025 37,489.00 1,183,184.00 62.22 Buy No

Ventas Dividend Calendar

Date Name Dividend *yield Currency
2024 Ventas Inc. 1.80 3.06 USD
2023 Ventas Inc. 1.80 3.61 USD
2022 Ventas Inc. 1.80 4.00 USD
2021 Ventas Inc. 1.80 3.52 USD
2020 Ventas Inc. 2.14 4.37 USD
2019 Ventas Inc. 3.17 5.49 USD
2018 Ventas Inc. 3.16 5.40 USD
2017 Ventas Inc. 3.12 5.19 USD
2016 Ventas Inc. 2.97 4.74 USD
2015 Ventas Inc. 3.04 5.39 USD
2014 Ventas Inc. 2.97 4.14 USD
2013 Ventas Inc. 2.74 4.77 USD
2012 Ventas Inc. 2.48 3.83 USD
2011 Ventas Inc. 2.30 4.17 USD
2010 Ventas Inc. 2.14 4.08 USD
2009 Ventas Inc. 2.05 4.69 USD
2008 Ventas Inc. 2.05 - USD
*Yield of the Respective Date

Ventas Calendar

Event Estimate Info Date
Earnings Report 0.132 USD Q2 2025 Earnings Release 07/31/2025
Earnings Report 0.147 USD Q3 2025 Earnings Release 10/30/2025
Earnings Report 0.150 USD Q4 2025 Earnings Release 02/18/2026
Earnings Report 0.140 USD Q1 2026 Earnings Release 05/06/2026

Ventas Past Events

Event Actual EPS Info Date
Annual General Meeting 0.190 USD Annual General Meeting 05/13/2025
Earnings Report 0.100 USD Q1 2025 Earnings Release 04/30/2025
Earnings Report 0.130 USD Q4 2024 Earnings Release 02/12/2025
Earnings Report 0.050 USD Q3 2024 Earnings Release 10/30/2024
Earnings Report 0.050 USD Q2 2024 Earnings Release 08/01/2024
Annual General Meeting -0.100 USD Annual General Meeting 05/14/2024
Earnings Report -0.040 USD Q1 2024 Earnings Release 05/01/2024
Earnings Report -0.230 USD Q4 2023 Earnings Release 02/14/2024
Earnings Report -0.180 USD Q3 2023 Earnings Release 11/02/2023
Earnings Report 0.260 USD Q2 2023 Earnings Release 08/03/2023
Annual General Meeting -0.120 USD Annual General Meeting 05/16/2023
Earnings Report 0.040 USD Q1 2023 Earnings Release 05/08/2023
Earnings Report -0.110 USD Q4 2022 Earnings Release 02/09/2023
Earnings Report 0.000 USD Q3 2022 Earnings Release 11/03/2022
Earnings Report -0.110 USD Q2 2022 Earnings Release 08/04/2022
Earnings Report 0.100 USD Q1 2022 Earnings Release 05/05/2022
Annual General Meeting 0.130 USD Annual General Meeting 04/27/2022
Earnings Report -0.100 USD Q4 2021 Earnings Release 02/17/2022

Ventas Profile

Ventas, Inc. engages in the acquisition and ownership of seniors housing and healthcare properties. It operates through the following segments: Senior Housing Operating Portfolio (SHOP), Outpatient Medical and Research Portfolio (OM&R), and Triple-net Leased Properties (NNN). The SHOP segment is involved in owning and investing in senior housing communities throughout the United States and Canada. The OM&R segment refers to acquiring, owning, development, leasing and managing outpatient medical buildings and research centers throughout the United States. The NNN segment focuses on investing and owning senior housing communities, skilled nursing facilities, long-term acute care facilities, freestanding inpatient rehabilitation facilities, and other healthcare facilities throughout the United States and the United Kingdom. The company was founded in 1983 and is headquartered in Chicago, IL. .

Moody’s Daily Credit Risk Score

Risk
  • Low
  • Medium
  • High
6
Moody’s Daily Credit Risk Score is a 1-10 score of a company’s credit risk, based on an analysis of the firm’s balance sheet and inputs from the stock market. The score provides a forward-looking, one-year measure of credit risk, allowing investors to make better decisions and streamline their work ow. Updated daily, it takes into account day-to-day movements in market value compared to a company’s liability structure.

Ventas Management

Name Job
Debra A. Cafaro Chairman & Chief Executive Officer
Gregory R. Liebbe Chief Accounting Officer, Senior VP & Controller
Robert F. Probst Chief Financial Officer & Executive Vice President
Bhavana Devulapally Chief Information Officer & Senior Vice President
James Justin Hutchens Chief Investment Officer
Brian Kenneth Wood Chief Tax Officer & Senior Vice President
Peter J. Bulgarelli Executive VP-Outpatient Medical & Research
Matthew J. Lustig Independent Director
Marguerite M. Nader Independent Director
Michael J. Embler Independent Director
Walter C. Rakowich Independent Director
Maurice S. Smith Independent Director
Melody C. Barnes Independent Director
Joe Vasquez Rodriguez Independent Director
Sumit Roy Independent Director
Theodore Ronald Bigman Independent Director
Sean P. Nolan Independent Director
Roxanne Mary Martino Lead Independent Director
Carey S. Roberts Secretary, EVP & General Counsel
Christian N. Cummings Senior Vice President-Asset Management
Tim Sanders Senior Vice President-Business Development
Bill J. Grant Senior Vice President-Investor Relations
Son Nguyen Treasury & Senior Vice President-Capital Markets
Kelly Meissner Vice President-Corporate ESG & Sustainability